(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.47%) $27.23
(0.41%) $924.25
(0.32%) $0.935
(0.80%) $11.04
(0.13%) $0.800
(-0.32%) $91.87
Live Chart Being Loaded With Signals
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform...
Stats | |
---|---|
Today's Volume | 47 369.00 |
Average Volume | 78 145.00 |
Market Cap | 60.39M |
EPS | NOK0 ( 2024-02-14 ) |
Next earnings date | ( NOK0 ) 2024-05-09 |
Last Dividend | NOK0 ( N/A ) |
Next Dividend | NOK0 ( N/A ) |
P/E | -2.05 |
ATR14 | NOK0.0450 (2.78%) |
PCI Biotech Holding ASA Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PCI Biotech Holding ASA Financials
Annual | 2023 |
Revenue: | NOK0 |
Gross Profit: | NOK-371 000 (0.00 %) |
EPS: | NOK-0.540 |
FY | 2023 |
Revenue: | NOK0 |
Gross Profit: | NOK-371 000 (0.00 %) |
EPS: | NOK-0.540 |
FY | 2022 |
Revenue: | NOK0 |
Gross Profit: | NOK-633 000 (0.00 %) |
EPS: | NOK-1.440 |
FY | 2021 |
Revenue: | NOK0.00 |
Gross Profit: | NOK0.00 (0.00 %) |
EPS: | NOK-0.843 |
Financial Reports:
No articles found.
PCI Biotech Holding ASA
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators